4 reasons why life sciences still fail women at the top, despite a female-majority workforce: report
3rd October 2025 Uncategorised 0Biopharma is set to lose two of the industry’s rare women CEOs—GSK’s Emma Walmsley and Merck KGaA’s Belén Garijo—leaving a dearth of women-helmed large life sciences companies.
More: 4 reasons why life sciences still fail women at the top, despite a female-majority workforce: report
Source: fierce
